Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 127

1.

25-Hydroxyvitamin D depletion does not exacerbate MPTP-induced dopamine neuron damage in mice.

Dean ED, Mexas LM, Cápiro NL, McKeon JE, DeLong MR, Pennell KD, Doorn JA, Tangpricha V, Miller GW, Evatt ML.

PLoS One. 2012;7(7):e39227. doi: 10.1371/journal.pone.0039227. Epub 2012 Jul 2.

PMID:
22768297
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

The TrkB-positive dopaminergic neurons are less sensitive to MPTP insult in the substantia nigra of adult C57/BL mice.

Ding YX, Xia Y, Jiao XY, Duan L, Yu J, Wang X, Chen LW.

Neurochem Res. 2011 Oct;36(10):1759-66. doi: 10.1007/s11064-011-0491-5. Epub 2011 May 12.

PMID:
21562748
[PubMed - indexed for MEDLINE]
3.

The role of the MYD88-dependent pathway in MPTP-induced brain dopaminergic degeneration.

Drouin-Ouellet J, Gibrat C, Bousquet M, Calon F, Kriz J, Cicchetti F.

J Neuroinflammation. 2011 Oct 11;8:137. doi: 10.1186/1742-2094-8-137.

PMID:
21989292
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Tyrosine hydroxylase and dopamine transporter expression following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurodegeneration of the mouse nigrostriatal pathway.

Jakowec MW, Nixon K, Hogg E, McNeill T, Petzinger GM.

J Neurosci Res. 2004 May 15;76(4):539-50.

PMID:
15114626
[PubMed - indexed for MEDLINE]
5.

Loss of spinal motor neurons and alteration of alpha-synuclein immunostaining in MPTP induced Parkinsonism in mice.

Vivacqua G, Biagioni F, Yu S, Casini A, Bucci D, D'Este L, Fornai F.

J Chem Neuroanat. 2012 Jul;44(2):76-85. doi: 10.1016/j.jchemneu.2012.04.003. Epub 2012 May 8.

PMID:
22580273
[PubMed - indexed for MEDLINE]
6.

Neuroprotection by tetrahydroxystilbene glucoside in the MPTP mouse model of Parkinson's disease.

Zhang L, Huang L, Chen L, Hao D, Chen J.

Toxicol Lett. 2013 Oct 24;222(2):155-63. doi: 10.1016/j.toxlet.2013.07.020. Epub 2013 Aug 1.

PMID:
23911879
[PubMed - indexed for MEDLINE]
7.

Combining nitric oxide release with anti-inflammatory activity preserves nigrostriatal dopaminergic innervation and prevents motor impairment in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease.

L'Episcopo F, Tirolo C, Caniglia S, Testa N, Serra PA, Impagnatiello F, Morale MC, Marchetti B.

J Neuroinflammation. 2010 Nov 23;7:83. doi: 10.1186/1742-2094-7-83.

PMID:
21092260
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Adaptive changes in the nigrostriatal pathway in response to increased 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurodegeneration in the mouse.

Bezard E, Jaber M, Gonon F, Boireau A, Bloch B, Gross CE.

Eur J Neurosci. 2000 Aug;12(8):2892-900.

PMID:
10971632
[PubMed - indexed for MEDLINE]
9.

Endogenous dynorphin protects against neurotoxin-elicited nigrostriatal dopaminergic neuron damage and motor deficits in mice.

Wang Q, Shin EJ, Nguyen XK, Li Q, Bach JH, Bing G, Kim WK, Kim HC, Hong JS.

J Neuroinflammation. 2012 Jun 13;9:124. doi: 10.1186/1742-2094-9-124.

PMID:
22695044
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

EGb761 protects against nigrostriatal dopaminergic neurotoxicity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice: role of oxidative stress.

Rojas P, Serrano-García N, Mares-Sámano JJ, Medina-Campos ON, Pedraza-Chaverri J, Ogren SO.

Eur J Neurosci. 2008 Jul;28(1):41-50. doi: 10.1111/j.1460-9568.2008.06314.x.

PMID:
18662333
[PubMed - indexed for MEDLINE]
11.

Regional and temporal expression of the peripheral benzodiazepine receptor in MPTP neurotoxicity.

Kuhlmann AC, Guilarte TR.

Toxicol Sci. 1999 Mar;48(1):107-16.

PMID:
10330690
[PubMed - indexed for MEDLINE]
Free Article
12.

Social enrichment attenuates nigrostriatal lesioning and reverses motor impairment in a progressive 1-methyl-2-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease.

Goldberg NR, Fields V, Pflibsen L, Salvatore MF, Meshul CK.

Neurobiol Dis. 2012 Mar;45(3):1051-67. doi: 10.1016/j.nbd.2011.12.024. Epub 2011 Dec 14.

PMID:
22198503
[PubMed - indexed for MEDLINE]
13.
14.

Neuroprotection in Parkinson models varies with toxin administration protocol.

Anderson DW, Bradbury KA, Schneider JS.

Eur J Neurosci. 2006 Dec;24(11):3174-82.

PMID:
17156378
[PubMed - indexed for MEDLINE]
15.

The mouse MPTP model: gene expression changes in dopaminergic neurons.

Kühn K, Wellen J, Link N, Maskri L, Lübbert H, Stichel CC.

Eur J Neurosci. 2003 Jan;17(1):1-12.

PMID:
12534964
[PubMed - indexed for MEDLINE]
16.

Recovery of hypothalamic tuberoinfundibular dopamine neurons from acute toxicant exposure is dependent upon protein synthesis and associated with an increase in parkin and ubiquitin carboxy-terminal hydrolase-L1 expression.

Benskey M, Behrouz B, Sunryd J, Pappas SS, Baek SH, Huebner M, Lookingland KJ, Goudreau JL.

Neurotoxicology. 2012 Jun;33(3):321-31. doi: 10.1016/j.neuro.2012.02.001. Epub 2012 Feb 9. Erratum in: Neurotoxicology. 2012 Jun;33(3):406.

PMID:
22342763
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Long-lasting reactive changes observed in microglia in the striatal and substantia nigral of mice after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.

Yasuda Y, Shinagawa R, Yamada M, Mori T, Tateishi N, Fujita S.

Brain Res. 2007 Mar 23;1138:196-202. Epub 2006 Dec 23.

PMID:
17275793
[PubMed - indexed for MEDLINE]
18.

Preventive role of PD-1 on MPTP-induced dopamine depletion in mice.

Jung HW, Son HY, Jin GZ, Park YK.

Cell Biochem Funct. 2010 Apr;28(3):217-23. doi: 10.1002/cbf.1642.

PMID:
20186864
[PubMed - indexed for MEDLINE]
19.

Quantitative assessment of gait and neurochemical correlation in a classical murine model of Parkinson's disease.

Wang XH, Lu G, Hu X, Tsang KS, Kwong WH, Wu FX, Meng HW, Jiang S, Liu SW, Ng HK, Poon WS.

BMC Neurosci. 2012 Nov 14;13:142. doi: 10.1186/1471-2202-13-142.

PMID:
23151254
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Behavioral motor recovery in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned squirrel monkey (Saimiri sciureus): changes in striatal dopamine and expression of tyrosine hydroxylase and dopamine transporter proteins.

Petzinger GM, Fisher B, Hogg E, Abernathy A, Arevalo P, Nixon K, Jakowec MW.

J Neurosci Res. 2006 Feb 1;83(2):332-47.

PMID:
16385585
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk